Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy

CMAJ. Canadian Medical Association Journal

Volumn 157, Issue 9, 1997, Pages 1245-1254

  Rey, Évelyne ^a,d   LeLorier, Jacques ^a   Burgess, Ellen ^b   Lange, Ian R ^c   Leduc, Line ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; OXPRENOLOL; PINDOLOL;

ANTIHYPERTENSIVE THERAPY; ARTICLE; AUSTRALIA; CANADA; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; EMERGENCY; FETUS DISTRESS; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; NEWBORN DISEASE; PLACENTA PERFUSION; PRACTICE GUIDELINE; PREGNANCY; PROTEINURIA; SEIZURE; SYMPOSIUM; SYSTOLIC BLOOD PRESSURE; UNITED STATES; WELLBEING;

EID: 0030697923     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classifications of hypertensive disorders in pregnancy. Can Med Assoc J 1997;157:715-25.
2. Moutquin JM, Garner PR, Burrows RF, Rey E, Helewa ME, Lange IR, et al. Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. Can Med Assoc J 1997;157:907-19.
3. Sackett DL. Rules of evidence and clinical recommendations on use of antithrombotic agents. Chest 1989;95(2 suppl 2):2S-4S.
4. Department of Health and Social Security. Report on confidential enquiries into maternal deaths in England and Wales 1982-84. London (UK): Her Majesty's Stationery Office; 1984, p. 10-9.
5. Management of preeclampsia. ACOG Tech Bull 1986;Feb(no 91).
6. Page EW, Christianson R. The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. Am J Obstet Gynecol 1976;125: 740-6.
7. Friedman FA, Neff RK. Pregnancy outcome as related to hypertension, edema, and proteinuria. In: Lindheimer MD, Katz AL, Zuspan FP, editors. Hypertension in pregnancy. New York: John Wiley & Sons; 1976. p. 13-22.
8. Mabie WC, Pernoll ML, Biswas MK. Chronic hypertension in pregnancy. Obstet Gynecol 1986;67:197-205.
9. Redman CW. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 1976;2:753-6.
10. Rubin PC, Butters L, Clark DM, Reynolds B, Sumner DJ, Steedman D, et al. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet 1983;1:431-4.
11. Hogstedt S, Lindeberg S, Axelsson O, Lindmark G, Rane A, Sandstrom B, et al. A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy. Acta Obstet Gynecol Scand 1985;64:505-10.
12. Sibai BA, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol 1987;70:323-7.
13. Phippard AF, Fischer WE, Horvath JS, Child AG, Korda AR, Henderson-Smart DJ, et al. Early blood pressure control improves pregnancy outcome in primigravid women with mild hypertension. Med J Aust 1991;154:378-82.
14. Cruickshank DJ, Robertson AA, Campbell DM, MacGillivray I. Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study. Eur J Obstet Gynecol Reprod Biol 1992;45:47-51.
15. Sibai BM, Barton JR, Akl S, Sarinoglu C, Mercer BM. A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol 1992; 167:879-84.
16. Redman CWG. A controlled trial of the treatment of hypertension in pregnancy: labetalol compared with methyldopa. In: Riley A, Symonds EM, editors. The investigation of labetalol in the management of hypertension in pregnancy. International Congress Series 591. Amsterdam: Excerpta Medica; 1982. p. 101-10.
17. Fidler J, Smith V, Fayers P, De Swiet M. Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. BMJ 1983;286:1927-30.
18. Gallery FD, Ross RM, Gyory AZ. Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. BMJ 1985;291: 563-6.
19. Jouppila P, Kirkinen P, Koivula A, Ylikorkala O. Labetalol does not alter placental and fetal blood flow or maternal prostanoids in pre-eclampsia. Br J Obstet Gynaecol 1986;93:543-7.
20. Moretti MM, Fairlie FM, Akl S, Khoury AD, Sibai BM. The effect of nifedipine therapy on letal and placental Doppler wave forms in preeclampsia remote from term. Am J Obstet Gynecol 1990;163:1844-8.
21. Meizner I, Paran E, Katz M, Holcberg G, Insler V. Flow velocity analysis of umbilical and uterine artery flow in pre-eclampsia treated with propanolol or pindolol. J Clin Ultrasound 1992;20:115-9.
22. Rey E. Effects of methyldopa on umbilical and placental artery blood flow velocity waveforms. Obstet Gynecol 1992;80:783-7.
23. Danti L, Valcamonico A, Soregaroli M, Frusca T, Zucca S, Gastaldi A. Fetal and maternal Doppler modifications during therapy with antihypertensive drugs. J Matern Fetal Invest 1994;4:19-23.
24. Jannet D, Carbonne B, Sebban F, Milliez, J. Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial. Obstet Gynecol 1994;84:354-9.
25. Leather HM, Humphreys DM, Baker P, Chadd MA. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet 1968;2:488-90.
26. Lardoux H, Blazquez, G, Leperlier E, Gerard J. Essai ouvert, comparatif avec tirage au sort pour le traitement de l'HTA gravidique modérée: methyldopa, acebutolol, labetalol. Arch Mal Coeur 1988;81:137-40.
27. Plouin PF, Breart G, Maillard F, Papiernik E, Relier JP. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomised controlled trial. Br J Obstet Gynaecol 1988;95:868-76.
28. Plouin PF, Breart G, Llado J, Dalle M, Keller ME, Goujon H, et al. A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension. Br J Obstet Gynaecol 1990;97:137-41.
29. Ellenbogen A, Jaschevatzky O, Davidson A, Anderman S, Grunstein S. Management of pregnancy-induced hypertension with pindolol - comparative study with methyldopa. Int J Gynaecol Obstet 1986;24:3-7.
30. Ismail AA, Medhat I, Tawfic TAS, Kholeif A. Evaluation of calcium-antagonist (nifedipine) in the treatment of pre-eclampsia. Int J Gynaecol Obstet 1993; 40:39-43.
31. Horvath JS, Phippard A, Korda A, Henderson-Smart DJ, Child A, Tiller DJ. Clonidine hydrochloride - a safe and effective antihypertensive agent in pregnancy. Obstet Gynecol 1985;66:634-8.
32. Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991;78:128-35.
33. Brent RL, Beckman D. Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors. Teratology 1991;43:543-6.
34. Thorpe-Beeston JG, Armar NA, Dancy M, Cochrane GW, Ryan G, Rodeck CH. Pregnancy and ACE inhibitors. Br J Obstet Gynaecol 1993;100:692-3.
35. Piper JM, Ray WA, Rosa FW. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstet Gynecol 1992;80:429-32.
36. Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication vs methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 1990;162:960-7.
37. Flowers CE, Grizzle JF, Easterling WE, Bonner OB. Chlorthiazide as a prophylaxis against toxemia of pregnancy. Am J Obstet Gynecol 1962;84:919-29.
38. Walker JJ, Crooks A, Erwin L, Calder AA. Labetalol in pregnancy-induced hypertension: fetal and maternal effects. In: Riley A, Symonds EM, editors. The investigation of labetalol in the management of hypertension in pregnancy. International Congress Series 591. Amsterdam: Excerpta Medica; 1982. p. 148-60.
39. Livingstone I, Craswell PW, Bevan EB, Smith MT, Eadie MJ. Propranolol in pregnancy - three-year prospective study. Clin Exp Hypertens B 1983;2:341-50.
40. Thorley KJ. Randomized trial of atenolol and methyldopa in pregnancy related hypertension [abstract]. Clin Exp Hypertens 1984;B3:168.
41. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ 1990;301:587-9.
42. Duley L. Any antihypertensive therapy in chronic hypertension. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Pregnancy and childbirth module of the Cochrane Database of Systematic Reviews. 1995 [updated 24 Feb 1995]. Available from the Canadian Medical Association, Ottawa.
43. Collins R, Duley L. Beta-blockers in the treatment of pre-eclampsia. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Pregnancy and childbirth module of the Cochrane Database of Systematic Reviews. 1995 [updated 24 Feb 1995]. Available from the Canadian Medical Association, Ottawa.
44. Collins R, Duley L. Any antihypertensive therapy for pregnancy hypertension. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Pregnancy and childbirth module of the Cochrane Database of Systematic Reviews. 1995 [updated 24 Feb 1995]. Available from the Canadian Medical Association, Ottawa.
45. Weseley AC, Douglas GM. Continuous use of chlorothiazide for prevention of toxemia of pregnancy. Obstet Gynecol 1962;19:355-8.
46. Cuadros A, Tatum HJ. The prophylactic and therapeutic use of bendroflumethiazide in pregnancy. Am J Obstet Gynecol 1964;89:891-7.
47. Campbell DM, MacGillivray I. The effect of a low calorie diet or a thiazide diuretic on the incidence of pre-eclampsia and on birthweight. Br J Obstet Gynecol 1975;82:572-7.
48. Collins R, Yusuf S, Peto R. Overview of randomised trials of diuretics in pregnancy. BMJ 1985;290:17-23.
49. Pickles CJ, Symonds EM, Pipkin FB. The fetal outcome in a randomised double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol 1989;96:38-43.
50. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 52 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994;171:818-22.
51. Dubois D, Petitcolas J, Temperville B, Klepper A, Catherine PH. Treatment of hypertension in pregnancy with β-adrenoceptor antagonists. Br J Clin Pharmacol 1982;13:375S-378S.
52. Sibai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol 1984;150:831-5.
53. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. Baltimore: Williams and Wilkins; 1994. p. 287/M.
54. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. Baltimore: Williams and Wilkins; 1994. p. 161-2/C.
55. Nifedipine product monograph. Elkhart (IN): Miles Pharmaceuticals; 1992.
56. Danielsson BR, Reiland S, Rundqvist E, Danielson M. Digital defects induced by vasodilating agents: relationship to reduction in uteroplacental blood flow. Teratology 1989;40:351-8.
57. Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L, et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996;174:823-8.
58. Dumez Y, Chobroutsky C, Hornych H, Amiel-Tison C. Neonatal effects of maternal administration of acebutolol. BMJ 1981;283:1077-9.
59. Cockburn J, Moar VA, Ounsted M, Redman CW. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982;1:647-9.
60. Symonds EM, Lamming GD, Jadoul F, Broughton Pipkin F. Clinical and biochemical aspects of the use of labetalol in the treatment of hypertension in pregnancy: comparison with methyldopa. In: Riley A, Symonds EM, editors. The investigation of labetalol in the management of hypertension in pregnancy. International Congress Series 591. Amsterdam: Excerpta Medica; 1982. p. 62-76.
61. Reynolds B, Butters L, Evans J, Adams T, Rubin PC. First year of life after the use of atenolol in pregnancy associated hypertension. Arch Dis Child 1984; 59:1061-3.
62. Waisman GD, Mayorgoi LM, Camera MI, Vignolo CA, Martinotti A. Magnesium plus nifedipine: Potentiation of hypotensive effect in preeclampsia? Am J Obstet Gynecol 1988;159:308-9.
63. Snyder SW, Cardwell MS. Neuromuscular blockage with magnesium sulfate and nifedipine. Am J Obstet Gynecol 1989;161:35-6.
64. Impey L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br J Obstet Gynecol 1993;100:959-61.
65. Ben-Ami M, Giladi Y, Shalev E. The combination of magnesium sulfate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol 1994;101: 262-3.
66. Mabie WC, Gonzalez AK, Sibai BM, Amon E. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 1987;70:328-33.
67. Martins-Costa S, Ramos JG, Barros E, Brano RM, Costa CA, Goldin IR. Randomized, controlled trial of hydralazine versus nifedipine in preeclamptic women with acute hypertension. Clin Exp Hypertens B 1992;11:25-44.
68. Paterson-Brown S, Robson SC, Redfern N, Walkinshaw SA, De Swiet M. Hydralazine boluses for the treatment of severe hypertension in pre-eclampsia. Br J Obstet Gynaecol 1994;101:409-13.
69. Garden A, Davey DA, Dommisse J. Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy. Clin Exp Hypertens B 1982;1: 371-83.
70. Michael CA. Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy. Aust N Z J Obstet Gynaecol 1986;26:26-9.
71. Seabe SJ, Moodley J, Becker P. Nifedipine in acute hypertensive emergencies in pregnancy. S Afr Med J 1989;76:248-50.
72. Fenakel K, Fenakel G, Appelman Z, Lurie S, Katz Z, Shoham Z. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 1991;77:331-7.
73. Kumar N, Batra YK, Bala I, Gopalan S. Nifedipine attenuates the hypertensive response to tracheal intubation in pregnancy-induced hypertension. Can J Anaesth 1993;40:329-3.
74. Ramanathan J, Sibai BM, Mabie WC, Chauhan D, Ruiz AG. The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsia. Am J Obstet Gynecol 1988;159:650-4.
75. Harper A, Murnaghan GA. Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol. Br J Obstet Gynaecol 1991;98:453-9.
76. Lurie S, Fenakel K, Friedman A. Effect of nifedipine on fetal heart rate in the treatment of severe pregnancy-induced hypertension. Am J Perinatol 1990; 7:285-6.
77. Morris JA, Arce JJ, Hamilton CJ, Davidson EC, Maidman JE, Clark JH, et al. The management of severe preeclampsia and eclampsia with intravenous diaxoxide. Obstet Gynecol 1977;49:675-80.
78. Neuman J, Weiss B, Rabello Y, Cabal L, Freeman RK. Diazoxide for the acute control of severe hypertension complicating pregnancy: a pilot study. Obstet Gynecol 1979;53(3 suppl):50S-55S.
79. Stempel JE, O'Grady PJ, Morton MJ, Johnston KA. Use of sodium nitroprusside in complications of gestational hypertension. Obstet Gynecol 1982;60:533-8.
80. Shoemaker CT, Meyers M. Sodium nitroprusside for control of severe hypertensive disease: a case report and discussion of potential toxicity. AM J Obstet Gynecol 1984;149:171-3.
81. Fidler J, Smith V, De Swiet M. A randomised study comparing timolol and methyldopa in hospital treatment of puerperal hypertension. Br J Obstet Gynaecol 1982;89:1031-4.
82. Griffis KR Jr, Martin JN Jr, Palmer SM, Martin RW, Morrison JC. Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension. Am J Perinatol 1989;6:437-41.
83. Barton JR, Hiett AK, Conover WB. The use of nifedipine during the postpartum period in patients with severe preeclampsia. Am J Obstet Gynecol 1990; 162:788-92.
84. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics 1994;93:137-50.
85. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345:1455-63.
86. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995;333:201-5.
87. Dommisse J. Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br J Obstet Gynaecol 1990;97:104-9.
88. Crowther CA. Magnesium sulphate versus diazepam in the management of eclampsia: a randomized controlled trial. Br J Obstet Gynaecol 1990;97:110-7.
89. Appleton MP, Kuehl TJ, Rachel MA, Adams HR, Knight AB, Gold WR. Magnesium sulfate versus phenytoin for seizure prophylaxis in pregnancy-induced hypertension. Am J Obstet Gynecol 1991;165(4 Pt 1):907-13.
90. Friedman SA, Lim KH, Baker CA, Repke JT. Phenytoin versus magnesium sulfate in preeclampsia: a pilot study. Am J Perinatol 1993;10:233-8.
91. Redman CW. Eclampsia still kills. BMJ 1988;296:1209-10.
92. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol 1988;158:80-3.
93. Burrows RF, Burrows EA. The feasibility of a control population for a randomized control trial of seizure prophylaxis in the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1995;173:929-35.
94. Roberts JM. Magnesium for preeclampsia and eclampsia. N Engl J Med 1995; 333:250-1.
95. Sibai BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol 1990;162:1141-5.
96. Robson SC, Redfern N, Seviour J, Campbell M, Walkinshaw S, Rudeck C, et al. Phenytoin prophylaxis in severe pre-eclampsia and eclampsia. Br J Obstet Gynaecol 1993;100:623-8.
97. Duley L. Phenytoin vs magnesium sulphate in severe pre-eclampsia. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Pregnancy and childbirth module of the Cochrane Database of Systematic Reviews. 1995 [updated 24 Feb 1995]. Available from the Canadian Medical Association, Ottawa.
98. Guzman ER, Conley M, Stewart R, Ivan J, Pitter M, Kappy K. Phenytoin and magnesium sulfate effects on fetal heart rate tracings assessed by computer analysis. Obstet Gynecol 1993;82:375-9.
99. National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy [review]. Am J Obstet Gynecol 1990;163(5 pt 1):1691-712.
100. Australasian Society for the Study of Hypertension in Pregnancy. Management of hypertension in pregnancy. Consensus statement. Melbourne: The Society; 1993. p. 1-46.